News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Dr. Reddy’s Laboratories, Inc. in Supply Deal with SYGNIS Pharma AG, Germany
November 26, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dr Reddy's Laboratories has signed an exclusive 10 year agreement with Germany-based Sygnis Pharma AG for the supply of an ingredient used in the treatment of stroke and other neurodegenrative disorders.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
Europe
MORE ON THIS TOPIC
Gene therapy
After Mortality-Marred Year, Sarepta Looks Ahead to Catalyst-Rich 2026
January 13, 2026
·
2 min read
·
Tristan Manalac
Business
JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff
January 13, 2026
·
3 min read
·
Nick Paul Taylor
Events
JPM26 Day 1: Obesity Front-and-Center, Q4 Sales Beats
January 13, 2026
·
3 min read
·
Tristan Manalac
Manufacturing
AbbVie Commits $100B in US R&D, Manufacturing, Winning Tariff, Pricing Exemptions
January 13, 2026
·
2 min read
·
Tristan Manalac
